GL1X · GenesisL1 explorer

MolNFT v1 · #188670 · protein

Ampicillin-ctx-M-15

7U4B · Beta-lactamase: “Ampicillin-ctx-M-15”. X-ray diffraction, 2 ligands (NW3, SO4), 7 pockets (best druggability 0.54). MolNFT v1 #188670 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7U4B
Type
protein
Length
780 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
C7S9T0
Ligands
NW3, SO4
Pockets
7 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CBeta-lactamase (EC 3.5.2.6)protein26043% helix, 19% strandC7S9T0

Ligands and binding sites

  • NW3 · (2S,4S)-2-[(1S)-1-{[(2S)-2-amino-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid · ligand · 3 copies · chains A, B, C
  • SO4 · Sulfate ion · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13300.540.7557NW3
21780.530.7924empty
31100.500.8122empty
42270.490.7530empty
51560.450.7520empty

Interfaces

2 interfaces between chains.

  • A–B · 767 Ų buried · 12 hydrogen bonds · protein-protein
  • A–C · 333 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 covalent (covalent ligand).

Compared structures

  • 7U4B · Ampicillin-CTX-M-15 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.